COMMUNIQUÉS West-GlobeNewswire

FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary

25/04/2018 - 22:30

WESTLAKE VILLAGE, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as [...]

Dyadic International to Announce First Quarter 2018 Financial Results and Host Conference Call on Thursday May 10, 2018

25/04/2018 - 22:30

JUPITER, Fla., April 25, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help [...]

Vital Therapies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

25/04/2018 - 22:30

SAN DIEGO, April 25, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today reported [...]

Burcon Announces Delisting From Nasdaq Capital Market

25/04/2018 - 22:22

VANCOUVER, British Columbia, April 25, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Company”), a leader in natural product extraction, purification and isolation [...]

Golden Leaf Holdings Appoints Rick Miller to Board of Directors

25/04/2018 - 22:05

TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced [...]

Conatus Pharmaceuticals to Report First Quarter 2018 Financial Results

25/04/2018 - 22:05

SAN DIEGO, April 25, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq: CNAT ) today announced that it will report financial results for the first quarter ended March 31, 2018, after the market close on [...]

Marrone Bio Innovations and Lidorr Chemicals Ltd. Sign Distribution Agreement in Israel

25/04/2018 - 22:05

DAVIS, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII ) (MBI) and Lidorr Chemicals Ltd. (LCL) today announced their partnership to distribute a range of novel biopesticides for [...]

BioTelemetry, Inc. Reports First Quarter 2018 Financial Results

25/04/2018 - 22:05

Company Exceeds Revenue and Adjusted EBITDA Expectations MALVERN, Pa., April 25, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT ), the leading mobile and wireless medical technology company focused on the [...]

LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%)

25/04/2018 - 22:05

BURLINGTON, Mass., April 25, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ), a provider of vascular devices, implants and services, today reported Q1 2018 results, provided guidance, and announced a $0 [...]

PRA Health Sciences Announces Retirement of Chief Financial Officer and Promotion of Michael Bonello to CFO

25/04/2018 - 22:04

RALEIGH, N.C., April 25, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH ) today announced that Linda Baddour, Executive Vice President and Chief Financial Officer will retire from her position as CFO, [...]

Ossur Hf : Updated financial calendar for the financial year 2018

25/04/2018 - 22:03

Announcement no. 32/2018 25 April 2018 Updated financial calendar for the financial year 2018 Compared with the previously announced financial calendar, company announcement no. 87/2017, 13 December 2017, Össur has [...]

Calithera Biosciences Announces CB-839 Abstracts Accepted for Presentation at ASCO 2018

25/04/2018 - 22:03

SOUTH SAN FRANCISCO, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, today [...]

Galapagos reports first quarter 2018 results

25/04/2018 - 22:02

Key Q1 2018 results: Group revenues of €44.8 million Operating loss €32.0 million Net loss of €37.3 million End of first quarter cash and cash equivalents €1.1 billion Clinical progress reported in CF and OA, [...]

Ossur Hf : Interim report Q1 2018

25/04/2018 - 22:01

Announcement no. 31/2018 Interim report Q1 2018 25 April 2018 Highlights Q1 2018 Sales amounted to USD 142 million, corresponding to 8% USD growth and 1% organic growth. The prosthetics segment grew 4% while sales of B [...]

Merit Medical Reports Record Revenues for First Quarter of 2018

25/04/2018 - 22:01

Q1 2018 worldwide revenue of $203.0 million ($197.9 million on a comparable, constant currency* basis), up 18.7% as reported (up 15.7% on a comparable, constant currency* basis) over Q1 2017 Q1 2018 core revenue* up 10. [...]

Xenon Pharmaceuticals to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference

25/04/2018 - 22:01

BURNABY, British Columbia, April 25, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's Chief Executive [...]

PRA Health Sciences, Inc. Reports First Quarter 2018 Results

25/04/2018 - 22:00

Net new business of $650.3 million; Net book-to-bill of 1.29 $701.8 million of revenue in the first quarter; 43.9% growth at actual foreign exchange rates and 40.7% growth on a constant currency basis compared to the [...]

Align Technology Announces First Quarter 2018 Financial Results

25/04/2018 - 22:00

Q1 revenues up 40.8% year-over-year to a record $436.9 million, and diluted EPS of $1.17 Q1 operating income up 59.2% year-over-year to $98.2 million or operating margin of 22.5% Q1 total Invisalign case shipments up 30 [...]

Align Technology to Introduce Two New iTero Scanners Featuring Greater Power and Portability

25/04/2018 - 22:00

Next-Generation iTero Element® 2 and New iTero Element Flex Expand iTero’s Leading Product Portfolio with More Choices and Streamlined Workflows for Every Type of Practice SAN JOSE, Calif., April 25, 2018 (GLOBE [...]